Table 1.

Comparison of the results between the dose distributions from original AXB‐calculated plans which were recalculated with the MC model. All DVH parameter results represent the difference values between the original AXB‐calculated plan and the MC‐recalculated AXB‐plan. Absolute dose values for various DVH parameters from different plans are normalized to the prescribed dose values

	Patient #1	Patient #2	Patient #3	Patient #4
PTV volume (cc)	4.2	15.1	25.6	100.4
GA	(%)	(%)	(%)	(%)
$3\mathrm{\%}/3\hspace{0.17em}\text{mm}$	98.9	95.5	99.4	99.6
$2\mathrm{\%}/2\hspace{0.17em}\text{mm}$	92.6	83.6	94.4	95.2
Parameters		Difference (%)
Lung
${\mathrm{D}}_{2\text{cm}}$	3.3	$-7.6$	$-2.7$	$-1.4$
PTV
${\mathrm{D}}_{95\mathrm{\%}}$	$-4.0$	$-11.1$	$-3.6$	$-1.8$
${\mathrm{D}}_{50\mathrm{\%}}$	$-7.3$	$-11.9$	$-4.4$	$-1.8$
${\mathrm{D}}_{5\mathrm{\%}}$	$-10.2$	$-9.4$	$-1.6$	$-0.2$
Lung‐GTV
${\mathrm{V}}_{30\mathrm{\%}}$	$-0.6$	$-1.5$	$-0.5$	$-0.2$
Spinal cord
${\mathrm{D}}_{max}$	$-0.2$	0.0	1.3	1.0
CI (absolute diff.)	0.03	0.13	0.05	0.01